Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
---|
12/07/2006 | WO2006129583A1 Pyrazolone derivative |
12/07/2006 | WO2006129524A1 Carbonyl compound remover |
12/07/2006 | WO2006129178A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
12/07/2006 | WO2006129164A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists |
12/07/2006 | WO2006128909A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases |
12/07/2006 | WO2006128824A1 Fungicidal 5-hydroxypyrazolines, method for the production thereof, and agents containing the same |
12/07/2006 | WO2006128823A1 Fungicidal n-benzyl-5-hydroxy-5-phenylpyrazolines, methods for the production thereof, and agents containing the same |
12/07/2006 | WO2006128815A1 Bicyclic 5-hydroxypyrazolines, method for producing the same and agents comprising the same |
12/07/2006 | WO2006079923A3 Form iv crystalline celecoxib |
12/07/2006 | WO2006068933A3 Mitotic kinesin inhibitors |
12/07/2006 | WO2006004742A3 α, β-UNSATURATED ESTERS AND ACIDS BY STEREOSELECTIVE DEHYDRATION |
12/07/2006 | US20060276656 Method for the production of fluoromethyl-substituted heterocycles |
12/07/2006 | US20060276650 Pyrazole compounds |
12/07/2006 | US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation |
12/07/2006 | US20060276487 New compounds useful for DPP-IV enzyme inhibition |
12/07/2006 | US20060276467 Sodium channel modulators |
12/07/2006 | CA2613678A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
12/06/2006 | EP1728790A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases |
12/06/2006 | EP1727820A2 Amine derivatives |
12/06/2006 | EP1727805A1 1-phenyl and 1-pyridylpyrazole derivatives and their use as pesticides |
12/06/2006 | EP1727804A1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides |
12/06/2006 | EP1727803A1 Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl)phenyl] ureas and intermediates thereof |
12/06/2006 | CN1875007A Process for the preparation of a trifluoromethylthioether |
12/06/2006 | CN1875006A Method for the production of fluoromethyl-substituted heterocycles |
12/06/2006 | CN1874777A 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
12/06/2006 | CN1288137C 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
12/05/2006 | US7144911 Anti-inflammatory medicaments |
12/05/2006 | US7144910 hydrolase enzyme antagonists such as N-{(6S,9R,11R)-2-[5-4-fluoroophenyl)-1-methyl-1H-pyrazol-3-yl]-5,6,7,8,9,10-hexahydro-6,9-methanobenzo[a][8]annulen-11-yl}-N'-(2,2,2-trifiuoroethyl)sulfamide that inhibit processing of amyloid precursor protein, useful in treating or preventing Alzheimer's disease |
12/05/2006 | US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases |
12/05/2006 | US7144888 Vanilloid receptor ligands and their use in treatments |
12/05/2006 | US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders |
11/30/2006 | WO2006127595A1 5-aminopyrazole carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof |
11/30/2006 | WO2006126718A1 Pyrazolopyrimidine derivative |
11/30/2006 | WO2006126695A1 Pyrazole compound and therapeutic agent for diabetes comprising the same |
11/30/2006 | WO2006126692A1 Pyrazole-1-carboxylic ester derivative, method for producing the same and method for producing pyrazole derivative |
11/30/2006 | WO2006125687A1 Heteroaroyl-substituted serine amides |
11/30/2006 | WO2006125370A1 Aromatic ether compounds,preparation and usage thereof |
11/30/2006 | WO2006092291A3 Method for producing alkyl anilides |
11/30/2006 | US20060270726 Phenyl substituted cyclic derivatives |
11/30/2006 | CA2609394A1 Pyrazole compound and therapeutic agent for diabetes comprising the same |
11/30/2006 | CA2609243A1 Heteroaroyl-substituted serine amides |
11/29/2006 | EP1726580A1 Aminophenylpropanoic acid derivative |
11/29/2006 | EP1725535A2 Hiv integrase inhibitors |
11/29/2006 | EP1725524A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
11/29/2006 | EP1076053B1 3-arylphenyl sulfide derivatives and insecticides and miticides |
11/29/2006 | EP1043995B1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS |
11/29/2006 | CN1871221A N-substituted pyrazolyl carboxanilides |
11/29/2006 | CN1871220A 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms |
11/29/2006 | CN1871219A Hexylcarboxanilide |
11/29/2006 | CN1871218A Isopentyl carboxanilides for combating undesired micro-organisms |
11/29/2006 | CN1871208A Aralkyl amines as cannabinoid receptor modulators |
11/29/2006 | CN1871204A Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl-pyrazole-4-carboxylic acid esters |
11/29/2006 | CN1287227C Electric photographic organic photoreceptor with charge transfer matter |
11/29/2006 | CN1286818C Method for preparing triazolinthionone derivative |
11/28/2006 | US7141678 Synthesis of diaryl pyrazoles |
11/28/2006 | US7141599 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
11/28/2006 | US7141585 Pyrazole derivatives |
11/28/2006 | CA2379640C Certain alkylene diamine-substituted heterocycles |
11/23/2006 | WO2006124874A2 Inhibitors of b-raf kinase |
11/23/2006 | WO2006123088A2 4- (thiazol-2-ylthioalkyl) -pyrazoles and their use as herbicides |
11/23/2006 | WO2006122546A1 Non-peptidic inhibitors of akap/pka interaction |
11/23/2006 | WO2006081034A3 Anti-inflammatory medicaments |
11/23/2006 | WO2006069155A3 Inhibitors of protein arginine methyl transferases |
11/23/2006 | WO2006051143A8 Heterocyclic ligands and the gadolinium (iii) complexes thereof with biomedical applications |
11/23/2006 | WO2005121096A3 A multicore indazolinone library |
11/23/2006 | US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
11/23/2006 | US20060264630 Antidiabetic agents; modulate insulin drug resistance |
11/23/2006 | US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE |
11/23/2006 | US20060264474 novel sulphonamide, sulphamate and sulphamide derivatives, comprising a m-disubstituted benzene or pyridine ring and a substituted pyrazole moiety, which inhibit the processing of APP by gamma -secretase, and hence are useful in the treatment or prevention of Alzheimer's disease |
11/23/2006 | US20060264430 Pyrazole derivative |
11/23/2006 | US20060264424 Arylsulfonamidobenzylic compounds |
11/23/2006 | US20060264419 Substituted pyrazoles |
11/23/2006 | CA2611896A1 Non-peptidic inhibitors of akap/pka interaction |
11/23/2006 | CA2607422A1 4- (thiazol-2-ylthioalkyl) -pyrazoles and their use as herbicides |
11/22/2006 | EP1724259A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indazol-5-yl)-octan amide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
11/22/2006 | EP1723102A2 N-substituted benzene sulfonamides |
11/22/2006 | EP1722766A2 Management of ophthalmologic disorders, including macular degeneration |
11/22/2006 | EP1399156B1 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity |
11/22/2006 | EP1322674B1 Control agents for living-type free radical polymerization, methods of polymerizing, emulsions and polymers with same |
11/22/2006 | EP1268435B1 4,5-dihydro-1h-pyrazole derivatives having cb 1-antagonistic activity |
11/22/2006 | CN1867555A Rearranged pentanols, a process for their production and their use as anti-inflammatory agents |
11/22/2006 | CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders |
11/22/2006 | CN1865247A N, N-diethyl amido phynyl methano pyrazolone preparation method |
11/22/2006 | CN1865219A 2- and 2,5-substituted phenylketo-enols |
11/22/2006 | CN1285572C Cannabinod receptor ligands |
11/21/2006 | US7138418 Pentafluorobenzenesulfonamides and analogs |
11/21/2006 | US7138414 Antidiabetic agents |
11/16/2006 | WO2006122230A1 P38 inhibitors and methods of use thereof |
11/16/2006 | WO2006120219A1 Pyrazolocarboxamides as fungicides |
11/16/2006 | WO2006120031A1 Process for the preparation of a carboxamide derivative |
11/16/2006 | WO2006119862A1 Process for the preparation of 5-alkylthioalkylamino-1-phenyl-pyrazoles |
11/16/2006 | WO2006086705B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
11/16/2006 | US20060258729 Antibacterial pyrazole carboxylic acid hydrazides |
11/16/2006 | US20060258723 Substituted Heteroaryl- and Phenylsulfamoyl Compounds |
11/16/2006 | CA2607590A1 Process for the preparation of 5-alkylthioalkylamino-1-phenyl-pyrazoles |
11/15/2006 | EP1721899A1 Process for the preparation of a carboxamide derivative |
11/15/2006 | EP1720878A1 Heteroaryl-fused pyrazolo derivatives |
11/15/2006 | EP1720860A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists |
11/15/2006 | EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
11/15/2006 | EP1720847A1 Histamine-3 receptor modulators |